Clinical Trial Update: A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of Opevesostat (MK-568) in Japanese participants with metastatic castration-resistant prostate cancer; the study MK-5684-005 is ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Opevesostat (MK-5684)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING